Document:

Form of Agreement of Purchase and Sale of Shares

 Exhibit 10.1 
 AGREEMENT FOR PURCHASE AND SALE OF SHARES 
 THIS AGREEMENT is entered into as of the
     day of August, 2006, between Telzuit Medical Technologies, Inc., 5422 Carrier Drive, Suite 306, Orlando, Florida 32819, (hereinafter the “Purchaser) and Todd LaVelle (hereinafter
“LaVelle”), 2197 Canton Road, Suite 107, Marietta, Georgia 30066, and Mike Evertsen (hereinafter “Evertsen”), 2197 Canton Road, Suite 107, Marietta, Georgia (when referred to collectively in this agreement LaVelle
and Evertsen are hereinafter the “Sellers”). 
 RECITALS 
 A. LaVelle is the owner of 100% of the issued and outstanding shares of capital stock of Cedars Diagnostic Labs, Inc., a Florida Corporation,
(hereinafter “Cedars”) and 50% of the issued and outstanding shares of capital stock of Atlantic Ultrasound, Inc., a Delaware Corporation (hereinafter “Atlantic”) (when referred to collectively in this
agreement Atlantic and Cedars are the “Companies”). 
 B. Evertsen is the owner of 50% of the issued and outstanding shares
of capital stock of Atlantic. 
 C. The Sellers desire to sell to the Purchaser, and the Purchaser desires to purchase from the Sellers, 100%
of the issued and outstanding shares of capital stock of the Companies. 
 THEREFORE, in consideration of the mutual promises and conditions
herein contained, the parties agree as follows: 
 AGREEMENT 
 1. Purchase and Sale of Stock. Subject to the terms and conditions of this Agreement, the Sellers agree to sell, transfer and assign to the
Purchaser, and the Purchaser agrees to purchase, at the Closing, as hereinafter defined, (a) Fifty (50) shares of Common Stock, no par value, of Atlantic from LaVelle and fifty (50) shares of common stock, no par value, from Evertsen,
such shares constituting all of the issued and outstanding capital stock of Atlantic, (b) (i) One Thousand (1,000) shares of Common Stock, par value $.01 per share, of Cedars from LaVelle, such shares constituting all of the issued
and outstanding capital stock of Cedars (collectively, the stock referenced in (a) and (b) above are referred to herein as the “Shares”). At the Closing, the Sellers shall deliver to the Purchaser a certificate or
certificates evidencing the Shares in form ready for transfer and duly endorsed to the Purchaser. At the Closing, and from time to time thereafter, the Sellers shall execute and deliver such other documents and instruments, and take such other
actions, as the Purchaser may reasonably request, in order more fully vest in the Purchaser and perfect his title to (x) all right, title and interest in and to the Shares and (y) any and all other right, title and interest, claim or
demand of any kind which the Sellers may have in, to, or upon any of the properties, assets or businesses of the Companies. 
 2. Election
under Section 338(h)(10) of the Internal Revenue Code. At the Purchaser’s election, the Purchaser and the Sellers shall file an election under § 338(h)(1) of the Internal Revenue Code, which shall permit the Purchaser, for tax
purposes, to treat the acquisition of the Shares as if the Purchaser had acquired the assets of the Companies. 
  

 1 

 3. Purchase Price and Payment. At the Closing, the Purchaser will pay the aggregate purchase price
for the Shares as follows: 
 a. $644,255.00 of the purchase price shall be paid by a bank’s cashier’s or certified
check, or via wire transfer, at the Closing on the date of Closing. 
 b. Purchaser shall deliver or transfer to the Sellers,
in the aggregate, 88,853 shares of its common stock registered for resale pursuant to its SB-2 Registration Statement. 
 Contemporaneous with the Closing,
Cedars shall pay from the proceeds of the closing the following inter-company payables: (i) $17,200 to PDS Image Holdings, LLC, (ii) $14,878 to Blue Medical Supply, Inc., and (iii) $12,177 Marietta Diagnostic Center, LLC (the
“Affiliate Payments”). Other than the Affiliate Payments, all other accounts payables owed to affiliates shall be deemed cancelled and satisfied. After payment of the Affiliate Payments referenced above, the aggregate liabilities of the
Companies (inclusive of equipment financing, equipment leases and trade payables) shall not exceed $187,656. 
 4. Intentionally
deleted. 
 5. Representations and Warranties by the Sellers as to Atlantic. The Sellers represent and warrant to the Purchaser,
concerning Atlantic, as follows: 
 a. Title to the Shares. The Sellers have good, absolute, and marketable title to
all of the issued and outstanding shares of capital stock of Atlantic free and clear of all liens, claims, encumbrances and restrictions of every kind. The Sellers have the complete and unrestricted right, power and authority to sell, transfer and
assign the Shares pursuant to this Agreement. The delivery of the Shares to the Purchaser, as herein contemplated, will vest in the Purchaser good, absolute and marketable title to all of the Shares, free and clear of all liens, claims, encumbrances
and restrictions of every kind. 
 b. Organization. Atlantic is a duly organized and validly existing Florida
corporation in good standing, with all requisite corporate power and authority to carry on its businesses as presently conducted. Atlantic is duly qualified as a foreign corporation in good standing in each jurisdiction wherein the nature of its
activities or its properties owned or leased makes such qualification necessary. Atlantic has no subsidiaries and has no direct or indirect interest in any other firm, corporation or business enterprise. 
 c. Capitalization and long-term indebtedness of Atlantic. 
 (i) Atlantic is authorized by its Articles of Incorporation to issue 1500 shares of Common Stock, no par value, 100 of which are duly and
validly issued and outstanding, fully paid, and nonassessable. Atlantic has no authority to issue any other capital stock or other securities. 
 (ii) The Sellers will deliver to the Purchaser upon request of Purchaser true copies of all instruments relating to Atlantic’s long-and short-term indebtedness. Atlantic is not now in default or violation of any
provision of its outstanding long-term or short-term indebtedness. 
  

 2 

 (iii) There are no outstanding options, contracts, commitments, warranties, agreements or
other rights of any character affecting or relating in any manner to the issuance of Atlantic’s capital stock or other securities, or entitling anyone to acquire Atlantic’s capital stock or other securities. 
 d. Financial Statements. The Sellers have furnished the Purchaser with a balance sheet for Atlantic as of July 31, 2006 (the
“2006 Atlantic Balance Sheet”) and a balance sheet for Atlantic as of February 28, 2005 and the related statements of income and retained earnings. The financial statements (i) are in accordance with the books and records of
Atlantic; (ii) fairly present the financial conditions of Atlantic as of such dates and the results of its operations for the periods therein specified; and (iii) except as otherwise disclosed in the schedules attached hereto, accurately
reflect all contracts and commitments of Atlantic. The 2006 Atlantic Balance Sheet discloses all of the debts, liabilities and obligations of any nature (whether absolute, accrued, contingent or otherwise and whether due or to become due) of
Atlantic at the 2006 Atlantic Balance Sheet date (except such debts, liabilities and obligations as are not required to be reflected therein in accordance with generally accepted accounting principles) and included appropriate reserves for all taxes
and other liabilities accrued or due at such dates but not yet payable. 
 e. Present Status. Since the date of the
2006 Atlantic Balance Sheet date, Atlantic has not; incurred any obligations or liabilities, absolute, accrued, contingent or otherwise, except current liabilities in the ordinary course of its businesses; discharged or satisfied any liens or
encumbrances, or paid any obligations or liabilities, except current Atlantic Balance Sheet liabilities and current liabilities incurred, in each case, since the 2006 Atlantic Balance Sheet date in the ordinary course of its business; declared or
made any shareholder payment or distribution or purchased or redeemed any of its securities or agreed to do so; mortgaged, pledged or subjected to lien, encumbrance or charge any of its assets; canceled any debt or claim; sold or transferred any
assets except sales from inventory in the ordinary course of its business; suffered any damage, destruction or loss (whether or not covered by insurance) materially affecting its properties, business or prospects; waived any rights of substantial
value; nor entered into any transactions other than in the ordinary course of its business. 
 f. Tax Returns and
Audits. Atlantic has duly filed all federal, state and local tax returns required to be filed by it and has paid all federal, state and local taxes required to be paid with respect to the periods covered by such returns. Atlantic is not
currently delinquent in the payment of any tax, assessment or governmental charge. Atlantic has not had any tax deficiencies proposed or assessed against it and has not executed any waiver of the statute of limitations on the assessment or
collection of any tax. Atlantic’s federal and state tax returns are not now being audited by the Internal Revenue Service nor does Atlantic have any knowledge of any intention by the Internal Revenue Service or the State of Florida to conduct
such audit. Atlantic has paid all federal, state and local taxes accrued prior to the date of the Closing. 
  

 3 

 g. Litigation. There are no legal actions, suits, arbitrations, or other legal,
administrative or other governmental proceedings pending or threatened against Atlantic, its properties, assets or businesses; and neither the Sellers nor Atlantic are aware of any facts which, to their knowledge, might result in any such action,
suit, arbitration or other proceeding. 
 h. Compliance with the Law and Other Instruments. The business and operations
of Atlantic have been and are being conducted in accordance with all applicable laws, rules and regulations of all authorities, except those which do not (either individually or in the aggregate) materially and adversely affect Atlantic or its
properties, assets, business or prospects. Performance of this Agreement will not result in any breach of, or constitute a default under, or result in the imposition of any lien or encumbrance upon any property of Atlantic under any arrangement,
agreement or other instrument to which Atlantic or the Sellers are a party or by which Atlantic or the Sellers are bound or affected, and will not violate the Articles of Incorporation, as amended, or the Bylaws of Atlantic. Atlantic is not in
violation of its Articles of Incorporation, as amended, its Bylaws, or of any indebtedness, mortgage, contract, lease or other agreement or commitment. 
 i. Title to Property and Assets. Atlantic has good, absolute and marketable title to all owned properties and assets, other than equipment identified as leased or financed equipment on Schedule 5(j) below,
including without limitation those reflected in the 2006 Atlantic Balance Sheet and those used or located on property controlled by Atlantic in its business, subject to no mortgage, pledge, lien, charge, security interest, encumbrance or restriction
except those which are disclosed on the 2006 Atlantic Balance Sheet as securing specified liabilities, or are disclosed in the Schedule of Assets referred to in subparagraph (5j) hereof. All the equipment of Atlantic is in operating condition,
reasonable wear and tear expected. Atlantic has not been threatened with any action or proceeding under any building or zoning ordinance, regulation or law. 
 j. Schedule of Assets. The Sellers have delivered to the Purchaser a separate Schedule of Assets, specifically referring to this
paragraph, containing: 
 (i) A true and complete legal description of all real properties owned and held by Atlantic, if any;

 (ii) A true and complete legal description of all real properties in which Atlantic has a leasehold interest, together with
a description of each indenture, lease, sublease or other instrument under which Atlantic claims or holds such leasehold interest. Atlantic has good and valuable leasehold interests in such properties, and all such instruments are in effect and
enforceable according to their respective terms; 
 (iii) A true and complete list of all patents, patent applications, patent
licenses, trademarks, trademark registrations and applications therefore, trade names, copyrights and copyright registrations and applications therefore, and any Food and Drug Administration approvals (hereinafter “FDA Approvals”)
owned or granted to Atlantic are listed on Schedule 5(j)(iii). 
  

 4 

 (iv) A true and complete list of all contracts between Atlantic and any insurance
companies whereby Atlantic has agreed to provide medical services to insureds of the insurance company and the insurance company has agreed that it will pay for services performed for its insureds by Atlantic (hereinafter “Atlantic Provider
Contracts”) are listed on Schedule 5(j)(iv). 
 (v) A true and complete list of all services provided by Atlantic for
which Medicare has approved Atlantic as a provider and for which Medicare will pay Atlantic when such services are provided by Atlantic for individuals participating in a Medicare plan are listed on Schedule 5(j)(v). 
 (vi) A complete schedule of all fire and other casualty and liability policies of Atlantic in effect on the date of this Agreement.

 (vii) A complete schedule of all machinery and equipment, automobiles, trucks, vans, or other vehicles, tools, furniture,
leasehold improvements, fixtures, customer deposits, utility deposits, equipment deposits, lease deposits or other deposits, and all other tangible personal property of every kind and nature owned or used in or necessary for the operation of the
business are listed on Schedule 5(j)(vii). 
 k. Atlantic Provider Contracts. To the best of the Sellers’
knowledge and belief, all of the Atlantic Provider Contracts listed in the Schedule of Assets referred to in Paragraph (5j), above, remain in full force and effect. Atlantic has in all respects performed all obligations required to be performed to
date and is not in material default in any respect under any of the Atlantic Provider Contracts, and the insurance companies that are parties to the Atlantic Provider Contracts are in material compliance therewith and are not in material default
thereunder. Furthermore the change in ownership of Atlantic, contemplated by this Agreement, will not result in the cancellation or termination of the Atlantic Provider Contracts. 
 l. Medicare Approvals. To the best of the Sellers’ knowledge and belief, the Medicare approvals Atlantic has received for its
services listed in the Schedule of Assets referred to in Paragraph (5j), subject only to the filing of a change of ownership form, will remain valid and effective. Atlantic remains a Medicare provider of those services and Medicare will pay Atlantic
for those services when provided to an individual participating in a Medicare plan. Furthermore, to the best of the Sellers’ knowledge and belief, the change in ownership of Atlantic, contemplated by this Agreement, will require the filing of a
change of ownership form but will not result in the cancellation, termination or withdrawal of the Medicare approvals listed in Atlantic’s Schedule of Assets. Atlantic is not in material default, in any respect, on any obligations it may have
to Medicare as a provider of services to individuals participating in a Medicare plan. 
  

 5 

 m. Patents Trademarks and FDA Approvals. Atlantic has FDA Approvals necessary in
the conduct of its business. Atlantic has received no notice of any claim that it is infringing upon or otherwise acting adversely to the rights of any person under, or in respect to, any copyrights, trademarks, trademark rights, patents, patent
rights or licenses owned by any person or persons, and there is no such claim or pending or threatened action with respect thereto. Atlantic has maintained any required FDA approvals, if any, and the transaction contemplated by this Agreement will
not affect these FDA Approvals. Atlantic is not obligated to pay any royalties or fees to any licensee or other claimant for any patent, trademark, trade name, copyright or other intangible asset. Atlantic has the unrestricted right to use (free and
clear of any rights or claims of others) all trade secrets, customer lists, manufacturing and other processes incident to the manufacture, use or sale of any and all products presently sold by it. 
 n. Contracts. Except as set forth on Schedule 5(n) attached hereto, Atlantic is not a party to, or otherwise bound by, any: written
or oral contract not made in the ordinary course of business; employment or consultant contract not terminable at will without cost or other liability; labor union contract; bonus, pension, profit sharing, retirement, share purchase, stock option,
hospitalization, group insurance, or similar employee benefits plan; real or personal property lease, as lessor or lessee; advertising or public relations contract; purchase, supply or service contract in excess of $500 each, or which is not
terminable without cost or expense on less than thirty (30) days’ notice; mortgage, conditional sales contract, security agreement, pledge agreement, trust receipt or any other agreement or arrangement whereby any of the assets or
properties of Atlantic are subject to a lien, encumbrance, charge or other restriction; license agreement, whether as licensee or licensor; contract or agreement involving any expenditure by Atlantic of more than $500; contract or agreement which is
not terminable by Atlantic on more than thirty (30) days’ notice. To the best of the Sellers’ knowledge and belief, Atlantic has in all respects performed all obligations required to be performed to date and is not in material default
in any respect under any of the contracts, agreements, leases, documents or other commitments to which it is a party or otherwise bound or affected. All parties having contracts with Atlantic are in material compliance therewith and are not in
material default thereunder. 
 o. Compensation of Officers and Others. Since the 2006 Atlantic Balance Sheet date,
there has not been any change in any compensation, commission, bonus or other remuneration payable to any officer, director, agent, employee or consultant of Atlantic, except for increases in the ordinary course of business consistent with prior
practice. 
 p. Inventories. The inventories of Atlantic which are reflected in the 2006 Atlantic Balance Sheet and all
inventory items which have been acquired since the 2006 Atlantic Balance Sheet date consist of goods of such quality and in such quantities as are salable in the ordinary course of its business with normal markup at prevailing market prices. Such
inventories were determined at the lower of cost or market. Since the 2006 Atlantic Balance Sheet date, Atlantic has continued to replenish its inventories in a normal and customary manner consistent with prior and prudent practice prevailing in its
business. 
  

 6 

 q. Records. The respective books of account and minute books of Atlantic are
correct, and reflect those transactions involving its business which properly should have been set forth in such books. 
 r.
Absence of certain Changes or Events. Since the 2006 Atlantic Balance Sheet date, there has not been any change in or any event or condition (financial or otherwise) affecting the properties, assets, liabilities, operations or prospects of
Atlantic other than changes in the ordinary course of its businesses, none of which has (either when taken by itself or when taken in conjunction with all other changes) been materially adverse. 
 s. Costs. Neither Atlantic nor the Sellers will be obligated in any way for any commission, fee, other remuneration to any finder,
dealer or the like employed by the Purchaser in connection with this Agreement or its negotiation, execution or performance. 
 t. Accounts Receivable. All of the accounts receivable of Atlantic are reflected on the 2006 Atlantic Balance Sheet and all of its accounts receivable which are reflection on the 2006 Atlantic Balance Sheet or have arisen since the
Atlantic Balance Sheet date (except such accounts receivable as have been collected since the Atlantic Balance Sheet date) are valid and to the best of the Sellers’ knowledge, are enforceable claims. 
 u. Purchase Commitments and Outstanding Bids. No purchase commitments of Atlantic are in excess of normal, ordinary and usual
requirements of its business, or were made at any price in excess of the then current market price, or contain terms and conditions more onerous than those usual and customary in the industry. 
 v. Insurance Policies. There are in full force all policies of fire, liability and other forms of insurance described in the
Schedule of Assets referred to in subparagraph j of this Paragraph 5. Such policies are in amounts and against such losses and risks as are generally maintained by comparable businesses. 
 w. Disclosure. No representation or warranty by the Sellers in this Agreement or in any writing furnished or to be furnished
pursuant hereto contains or will contain any untrue statement of a material fact, or omit or will omit to state any material fact required to make the statements herein or therein contained not misleading. 
 6. Representations and Warranties by LaVelle as to Cedars. LaVelle represents and warrant to the Purchaser, concerning Cedars, as follows:

 a. Title to the Shares. LaVelle has good, absolute, and marketable title to all of the issued and outstanding shares
of capital stock of Cedars free and clear of all liens, claims, encumbrances and restrictions of every kind. LaVelle has the complete and unrestricted right, power and authority to sell, transfer and assign the Shares pursuant to this Agreement. The
delivery of the Shares to the Purchaser, as herein contemplated, will vest in the Purchaser good, absolute and marketable title to all of the Shares, free and clear of all liens, claims, encumbrances and restrictions of every kind. 
  

 7 

 b. Organization. Cedars is a duly organized and validly existing Florida
corporation in good standing, with all requisite corporate power and authority to carry on its businesses as presently conducted. Cedars is duly qualified as a foreign corporation in good standing in each jurisdiction wherein the nature of its
activities or its properties owned or leased makes such qualification necessary. Cedars has no subsidiaries and has no direct or indirect interest in any other firm, corporation or business enterprise. 
 c. Capitalization and long-term indebtedness of Cedars. 
 (i) Cedars is authorized by its Articles of Incorporation, to issue 100,000 shares of Common Stock, par value $.01 per share, 1,000
of which are duly and validly issued and outstanding, fully paid, and nonassessable. Cedars has no authority to issue any other capital stock or other securities. 
 (ii) LaVelle will deliver to the Purchaser upon request of Purchaser true copies of all instruments relating to Cedars’ long-and
short-term indebtedness. Cedars is not in any default or violation of any provisions of its outstanding long-term or short-term indebtedness. 
 (iv) There are no outstanding options, contracts, commitments, warranties, agreements or other rights of any character affecting or relating in any manner to the issuance of Cedars’ capital stock or other
securities, or entitling anyone to acquire Cedars’ capital stock or other securities. 
 d. Financial Statements.
LaVelle has furnished the Purchaser with a balance sheet for Cedars as of July 31, 2006 (the “2006 Cedars Balance Sheet”) and Cedars Balance Sheet for Cedars as of December 31, 2004 and the related statement of income and
retained earnings for the year ended 2004, prepared by Goldman and Co., Certified Public Accountants. The financial statements for Cedars (i) are in accordance with the books and records of Cedars; (ii) fairly present the financial
conditions of Cedars as of such dates and the results of its operations for the periods therein specified, and (iii) and (iii) except as otherwise disclosed in the schedules attached hereto, accurately reflect all contracts and commitments
of Atlantic. The 2006 Cedars Balance Sheet discloses all of the debts, liabilities and obligations of any nature (whether absolute, accrued, contingent or otherwise and whether due or to become due) of Cedars at the 2006 Cedars Balance Sheet date
(except such debts, liabilities and obligations as are not required to be reflected therein in accordance with generally accepted accounting principles) and included appropriate reserves for all taxes and other liabilities accrued or due at such
dates but not yet payable. 
 e. Present Status. Since the 2006 Cedars Balance Sheet date, Cedars has not; incurred any
obligations or liabilities, absolute, accrued, contingent or otherwise, except current liabilities in the ordinary course of its businesses; discharged or satisfied any liens or encumbrances, or paid any obligations or liabilities, except current
2006 Cedars Balance Sheet liabilities and current liabilities incurred, in each case, since the 2006 Cedars Balance Sheet date in the ordinary course of its business; declared or made any shareholder payment or distribution or purchased or redeemed
any of its securities or 
  

 8 

 agreed to do so; mortgaged, pledged or subjected to lien, encumbrance or charge any of its assets;
canceled any debt or claim; sold or transferred any assets except sales from inventory in the ordinary course of its business; suffered any damage, destruction or loss (whether or not covered by insurance) materially affecting its properties,
business or prospects; waived any rights of substantial value; nor entered into any transactions other than in the ordinary course of its business. 
 f. Tax Returns and Audits. Cedars has duly filed all federal, state and local tax returns required to be filed by it and has paid all federal, state and local taxes required to be paid with respect to the
periods covered by such returns. Cedars is not now delinquent in the payment of any tax, assessment or governmental charge. Cedars has not had any tax deficiencies proposed or assessed against it and has not executed any waiver of the statute of
limitations on the assessment or collection of any tax. Cedars’ federal and state tax returns are not now being audited by the Internal Revenue Service nor does Cedars have any knowledge of any intention by the Internal Revenue Service or the
State of Florida to conduct such audit. Cedars has paid all federal, state and local taxes accrued prior to the Closing Date. 
 g. Litigation. There are no legal actions, suits, arbitrations, or other legal, administrative or other governmental proceedings pending or threatened against Cedars, its properties, assets or businesses; and neither LaVelle nor
Cedars are aware of any facts which, to their knowledge, might result in any such action, suit, arbitration or other proceeding. 
 h. Compliance with the Law and Other Instruments. The business and operations of Cedars have been and are being conducted in accordance with all applicable laws, rules and regulations of all authorities, except those which do not
(either individually or in the aggregate) materially and adversely affect Cedars or its properties, assets, business or prospects. Performance of this Agreement will not result in any breach of, or constitute a default under, or result in the
imposition of any lien or encumbrance upon any property of Cedars under any arrangement, agreement or other instrument to which Cedars or LaVelle are a party or by which Cedars or LaVelle are bound or affected, and will not violate the Articles of
Incorporation, as amended, or the Bylaws of Cedars. Cedars is not in violation of its Articles of Incorporation, as amended, its Bylaws, or of any indebtedness, mortgage, contract, lease or other agreement or commitment. 
 i. Title to Property and Assets. Cedars has good, absolute and marketable title to all owned properties and assets, other than
equipment identified as leased equipment on Schedule 6(j) below, including without limitation those reflected in the 2006 Cedars Balance Sheet and those used or located on property controlled by Cedars in its business, subject to no mortgage,
pledge, lien, charge, security interest, encumbrance or restriction except those which are disclosed on the 2006 Cedars Balance Sheet as securing specified liabilities, or are disclosed in the Schedule of Assets referred to in subparagraph
(6j) hereof. All the equipment of Cedars is in good condition and repair, reasonable wear and tear expected. Cedars has not been threatened with any action or proceeding under any building or zoning ordinance, regulation or law. 
  

 9 

 j. Schedule of Assets. LaVelle has delivered to the Purchaser a separate Schedule
of Assets, specifically referring to this paragraph, containing: 
 (i) A true and complete legal description of all real
properties owned and held by Cedars; 
 (ii) A true and complete legal description of all real properties in which Cedars has
a leasehold interest, together with a description of each indenture, lease, sublease or other instrument under which Cedars claims or holds such leasehold interest. Cedars has good and valuable leasehold interests in such properties, and all such
instruments are in effect and enforceable according to their respective terms; 
 (iii) A true and complete list of all
patents, patent applications, patent licenses, trademarks, trademark registrations and applications therefore, trade names, copyrights and copyright registrations and applications therefore, and any Food and Drug Administration approvals
(hereinafter “FDA Approvals”) owned or granted to Cedars are listed on Schedule 6(j)(iii). 
 (iv) A true and
complete list of all contracts between Cedars and any insurance companies whereby Cedars has agreed to provide medical services to insureds of the insurance company and the insurance company has agreed that it will pay for services performed for its
insureds by Cedars (hereinafter “Cedars Provider Contracts”) are listed on Schedule 6(j)(iv). 
 (v) A true
and complete list of all services provided by Cedars for which Medicare has approved Cedars as a provider and for which Medicare will pay Cedars when such services are provided by Cedars for individuals participating in a Medicare plan are listed on
Schedule 6(j)(v). 
 (vi) A complete schedule of all fire and other casualty and liability policies of Cedars in effect on the
date of this Agreement. 
 (vii) A complete schedule of all machinery and equipment, automobiles, trucks, vans, or other
vehicles, tools, furniture, leasehold improvements, fixtures, customer deposits, utility deposits, equipment deposits, lease deposits or other deposits, and all other tangible personal property of every kind and nature owned or used in or necessary
for the operation of the Business are listed on Schedule 6(j)(vii). 
 Cedars Provider Contracts. All of the Cedars
Provider Contracts listed in the Schedule of Assets referred to in Paragraph (6j), above, remain in full force and effect. Cedars has in all respects performed all obligations required to be performed to date and is not in material default in any
respect under any of the Cedars Provider Contracts, and the insurance companies that are parties to the Cedars Provider Contracts are in material compliance therewith and are not in material default thereunder. Furthermore, the change in ownership
of Cedars, contemplated by this Agreement, will not result in the cancellation or termination of the Cedars Provider Contracts. 
  

 10 

 k. Medicare Approvals. The Medicare approvals Cedars has received for its services
listed in the Schedule of Assets referred to in Paragraph (6j) subject only to the filing of a change of ownership form will remain valid and effective. Cedars remains a Medicare provider of those services and Medicare will pay Cedars for those
services when provided to an individual participating in a Medicare plan. Furthermore, the change in ownership of Cedars, contemplated by this Agreement, will require the filing of a change of ownership form but will not result in the cancellation,
termination or withdrawal of the Medicare approvals listed in Cedar’s Schedule of Assets. Cedars is not in material default, in any respect, on any obligations it may have to Medicare as a provider of services to individuals participating in a
Medicare plan. 
 l. Patents Trademarks and FDA Approvals. Cedars has FDA Approvals necessary in the conduct of its
business. Cedars has received no notice of any claim that it is infringing upon or otherwise acting adversely to the rights of any person under, or in respect to, any copyrights, trademarks, trademark rights, patents, patent rights or licenses owned
by any person or persons and there is no such claim or pending or threatened action with respect thereto. Cedars has maintained any required FDA approvals, if any, and the transaction contemplated by this Agreement will not affect these FDA
Approvals. Cedars is not obligated to pay any royalties or fees to any licensee or other claimant for any patent, trademark, trade name, copyright or other intangible asset. Cedars has the unrestricted right to use (free and clear of any rights or
claims of others) all trade secrets, customer lists, manufacturing and other processes incident to the manufacture, use or sale of any and all products presently sold by it. 
 m. Contracts. Except as set forth on Schedule 6(m) attached hereto, Cedars is not a party to, or otherwise bound by, any: written
or oral contract not made in the ordinary course of business; employment or consultant contract not terminable at will without cost or other liability; labor union contract; bonus, pension, profit sharing, retirement, share purchase, stock option,
hospitalization, group insurance, or similar employee benefits plan; real or personal property lease, as lessor or lessee; advertising or public relations contract; purchase, supply or service contract in excess of $500 each, or which is not
terminable without cost or expense on less than thirty (30) days’ notice; mortgage, conditional sales contract, security agreement, pledge agreement, trust receipt or any other agreement or arrangement whereby any of the assets or
properties of Cedars are subject to a lien, encumbrance, charge or other restriction; license agreement, whether as licensee or licensor; contract or agreement involving any expenditure by Cedars of more than $500; contract or agreement which is not
terminable by Cedars on more than thirty (30) days’ notice. Cedars has in all respects performed all obligations required to be performed to date and is not in material default in any respect under any of the contracts, agreements, leases,
documents or other commitments to which it is a party or otherwise bound or affected. All parties having contracts with Cedars are in material compliance therewith and are not in material default thereunder. 
 o. Compensation of Officers and Others. Since the 2006 Cedars Balance Sheet date, there has not been any change in any
compensation, commission, bonus or other remuneration payable to any officer, director, agent, employee or consultant of Cedars, except for increases in the ordinary course of business consistent with prior practice. 
  

 11 

 p. Inventories. The inventories of Cedars which are reflected in the 2006 Cedars
Balance Sheet and all inventory items which have been acquired since the 2006 Cedars Balance Sheet date consist of goods of such quality and in such quantities as are salable in the ordinary course of its business with normal markup at prevailing
market prices. Such inventories were determined at the lower of cost or market. Since the 2006 Cedars Balance Sheet date, Cedars has continued to replenish its inventories in a normal and customary manner consistent with prior and prudent practice
prevailing in its business. 
 q. Records. The respective books of account and minute books of Cedars are correct, and
reflect those transactions involving its business which properly should have been set forth in such books. 
 r. Absence of
certain Changes or Events. Since the 2006 Cedars Balance Sheet date, there has not been any change in or any event or condition (financial or otherwise) affecting the properties, assets, liabilities, operations or prospects of Cedars other than
changes in the ordinary course of its businesses, none of which has (either when taken by itself or when taken in conjunction with all other changes) been materially adverse. 
 s. Costs. Neither Cedars nor LaVelle will be obligated in any way for any commission, fee, other remuneration to any finder, dealer
or the like employed by the Purchaser in connection with this Agreement or its negotiation, execution or performance. 
 t.
Accounts Receivable. All of the accounts receivable of Cedars are reflected on the 2006 Cedars Balance Sheet and all of its accounts receivable which are reflected on the 2006 Cedars Balance Sheet or have arisen since the 2006 Cedars Balance
Sheet date (except such accounts receivable as have been collected since the 2006 Cedars Balance Sheet date) are valid and, to the extent of LaVelle’s knowledge, are enforceable claims. 
 u. Purchase Commitments and Outstanding Bids. No purchase commitments of Cedars are in excess of normal, ordinary and usual
requirements of its business, or were made at any price in excess of the then current market price, or contain terms and conditions more onerous than those usual and customary in the industry. 
 v. Insurance Policies. There are in full force all policies of fire, liability and other forms of insurance described in the
Schedule of Assets referred to in subparagraph j of this Paragraph 5. Such policies are in amounts and against such losses and risks as are generally maintained by comparable businesses. 
 w. Disclosure. No representation or warranty by LaVelle in this Agreement or in any writing furnished or to be furnished pursuant
hereto contains or will contain any untrue statement of a material fact, or omit or will omit to state any material fact required to make the statements herein or therein contained not misleading. 
  

 12 

 7. Representations and Warranties By Purchaser. The Purchaser represents and warrants to the
Sellers that it is authorized, by appropriate action of its directors, to enter into this Agreement and to consummate all the transactions contemplated by the Agreement including, without limitation, the issuance of its shares of common stock
referred to in subparagraph (3)(b) hereof and that no shareholder approval is required. 
 8. Actions of the Companies Pending
Closing. The Sellers agree that from the date hereof through the Closing Date: 
 a. Operations. Unless the
Purchaser consents in writing to the contrary, the Sellers will cause the Companies to operate only in the ordinary course of their businesses; and to not enter into any transaction or perform any act which would constitute a breach of the
representations, warranties or agreements contained herein. 
 b. Access to Records. The Sellers will cause the
Companies to afford the Purchaser access, during normal business hours, to all of their business operations, properties, books, files and records and will cooperate in the Purchaser’s examination thereof. No such examination, however, shall
constitute a waiver or relinquishment by the Purchaser of his right to rely upon the Sellers’ covenants, representations and warranties as made herein or pursuant hereto. Except as and to the extent required by law, the Purchaser will not
disclose or use and will direct its representatives not to disclose or use to the detriment of the Companies or the Sellers, any Confidential Information (as defined below) with respect to the Companies or the Sellers furnished, or to be furnished,
by either the Companies or the Sellers or their respective representatives to the Purchaser or its representatives at any time or in any manner other than in connection with its evaluation of the transaction proposed in this letter. Notwithstanding
the foregoing, the Sellers agree and acknowledge that the Purchaser may file an 8-K under the Securities Exchange Act, as amended, disclosing the terms of this transaction, attach this Agreement to the 8-K, and issue a press release announcing that
it has entered into this Agreement. For purposes of this Paragraph, “Confidential Information” means any information about the Companies or the Sellers stamped “confidential” or identified in writing as such to the Purchaser by
the Companies or the Sellers promptly following its disclosure, unless (a) such information is already known to the Purchaser or its representatives or to others not bound by a duty of confidentiality at the time of its disclosure or if such
information becomes publicly available through no fault of the Purchaser or its representatives; (b) the use of such information is necessary or appropriate in making any filing or obtaining any consent or approval required for the consummation
of the possible acquisition; or (c) the furnishing or use of such information is required by or necessary or appropriate in connection with legal proceedings. Upon the written request of the Companies or the Sellers, the Purchaser will promptly
return to the Companies or the Sellers or destroy any Confidential Information in its possession and certify in writing to the Companies and the Sellers that it has done so. 
  

 13 

 c. Compliance. The Sellers will cause the Companies and their officers and
employees to comply with all applicable provisions of this Agreement. 
 d. Exclusive Dealing. 
 (i) Neither the Companies nor the Sellers will, directly or indirectly, through any representative or otherwise, solicit or entertain
offers from, negotiate with or in any manner encourage, discuss, accept or consider any proposal of any other person relating to the acquisition of the Companies, their assets or businesses, in whole or in part, or the shares of their capital stock,
whether directly or indirectly, through purchase, merger, consolidation or otherwise; and 
 (ii) Either the Companies or the
Sellers will, as the case may be, immediately notify the Purchaser regarding any contact between the Companies, the Sellers or their respective representatives and any other person regarding any such offer or proposal or any related inquiry.

 9. Conditions Precedent to Obligations of Purchaser. Unless waived, in whole or in part, in writing by the Purchaser, the
obligations of the Purchaser hereunder are subject to the fulfillment prior to or at the Closing, of each of the following conditions: 
 a. No Material Errors. The representations and warranties of both Sellers, as to Atlantic, in Paragraph 5, hereof, and of LaVelle, as to Cedars, in Paragraph 6, hereof, shall be deemed to have been made again
on the Closing Date and then be true and correct, subject to any changes contemplated by this Agreement. The Sellers shall have performed all of the obligations to be performed by them hereunder on or prior to the Closing Date. 
 b. Certificate of Officers. The Companies shall have delivered to the Purchaser a certificate dated on the Closing Date, executed
by their Presidents and Secretaries, certifying that the conditions specified in subparagraphs (a), (c) and (e) of this Paragraph 9 have been fulfilled, and the representations and warranties are true and correct. 
 c. Resignation of Directors and Officers. The Sellers shall have delivered to the Purchaser the written resignations of the
directors and officers of the Companies. 
 d. Intentionally deleted. 
 e. Intentionally deleted. 
 f. Covenant Not to Compete. The Sellers shall enter into a Non-Competition Agreement in form reasonably satisfactory to the Purchaser providing, among other matters, for five years following the Closing Date,
he will not, directly or indirectly, within the State of Florida, enter into or engage generally in direct competition with the Companies in the business of medical imaging, either as a partner or joint venturer, or as an employee or agent for any
person, or as an officer, director, shareholder or otherwise. Not withstanding the foregoing, the agreement shall not restrict the rights of the Sellers to engage in the business of selling medical supplies. 
  

 14 

 g. Consents. The Purchasers shall have obtained all necessary consents to the
change in ownership. 
 h. Employment Related Compensation. Intentionally deleted. 
 i. Completion of Audit. The Purchaser, at its expense, may cause the Companies financial statements to be audited. The closing will
be contingent upon the Purchaser’s receipt of audited financial statements. 
 j. Other Matters. All corporate and
other proceedings and action taken in connection with the transactions contemplated hereby and all certificates, opinions, agreements, instruments and documents mentioned herein or incident to any such transaction shall be satisfactory in form and
substance to the Purchaser and his counsel. 
 10. Nature and Survival of Representations and Warranties. All statements of fact
contained in any memorandum, certificate, instrument or other document delivered by or on behalf of the Sellers for information or reliance pursuant to this Agreement shall be deemed representations and warranties by the Sellers under this
Agreement. All representations and warranties of the parties shall survive the Closing and all inspections, examinations or audits on behalf of the parties shall expire two years following the Closing Date. 
 11. Indemnification. The Sellers hereby agree to indemnify and hold harmless the Purchaser against, and in respect of, actual damages (as
hereinafter defined). Damages, as used herein, shall include any claim, action, demand, loss, cost, expense, liability (joint or several), penalty and other damage, including without limitation, reasonable counsel fees reasonably required and other
costs and expenses actually incurred in investigation or in attempting to avoid same or oppose imposition thereof or in enforcing this indemnity, resulting to Purchaser from any misrepresentation made by Sellers in this Agreement, breach of any
warranties made by the Sellers in this Agreement, or breach or default in the performance by the Sellers of any of the obligations to be performed by it hereunder. Notwithstanding the scope of the Sellers’ representations and warranties herein,
or of any individual representation or warranty, or any disclosure to the Purchaser, herein or pursuant hereto, or the definition of damages contained in the preceding sentence, or the Purchaser’s knowledge of any fact or facts at or prior to
the Closing, damages shall also include: all debts, liabilities and obligations (whether absolute, accrued, contingent or otherwise and whether due or to become due) of the Companies on the 2006 Cedars Balance Sheet Date not reflected in the 2006
Cedars Balance Sheet, whether known or unknown by the Sellers; all claims, actions, demands, losses, costs, expenses and liabilities resulting from any litigation involving the Companies which arose prior to the date of Closing whether or not
disclosed to the Purchaser; all claims, actions, demands, losses, costs, expenses, liabilities and penalties resulting from (i) the Companies’ failure to own, possess and have good title; or (ii) any claim or action with respect to
the matters described in clauses (i) or (ii); all claims, actions, demands, losses, costs, expenses, liabilities or penalties resulting from the Companies’ failure to perform any obligation required by them to be performed at or prior to
the date hereof or at or prior to the Closing Date, or by reason of any default of the Companies, at the date hereof or at the Closing Date, under any of the contracts, agreements, leases, documents or other commitments to which they are parties or
otherwise bound or affected; and all losses, costs and expenses (including without limitation all fees and disbursement of counsel) relating to 
  

 15 

 damages. The Sellers shall reimburse the Purchaser on demand for all payments made by the Purchaser at any time after
Closing, based upon the judgment of any court of competent jurisdiction or pursuant to a bona fide compromise or settlement of claims, demands or actions, in respect of any damages to which the foregoing indemnity relates. 
 The Purchaser agrees to give the Sellers prompt written notice of any litigation threatened or instituted against the Companies which might constitute
the basis of a claim for indemnity by the Purchaser against the Sellers. 
 12. Records of the Companies. For a period of five years
following the Closing Date, the books of account and records of the Companies pertaining to all periods prior to the Closing Date shall be available for inspection by the Sellers for use in connection with tax audits. 
 13. Miscellaneous. 
 a. Expenses. All of the parties shall bear all expenses incurred by them in connection with this Agreement and in the consummation of the transactions contemplated hereby and preparation thereof. 
 b. Amendment and Waiver. This Agreement may be amended or modified at any time and in all respects by an instrument in writing
executed by the Purchaser and the Sellers. 
 c. Non Assignability and No Third Party Beneficiaries. Neither this
Agreement nor any right created by it shall be assignable by either the Sellers (or their successors in interest) or the Purchaser without the prior written consent of the other, except for an assignment incident to a merger, consolidation or
reorganization of either party. Nothing in this Agreement, expressed or implied, is intended to confer upon any person, other than the parties hereto and their successors, any rights or remedies under or by reason of this Agreement. 
 d. Notices. Any notices, communication, request, reply or advice (hereinafter severally and collectively called
“Notice”) provided for or permitted to be given by this Agreement, made, or accepted by either party to the other must be in writing and may be given or be served by depositing the same in the United States mail, addressed to the
party to be notified, postage prepaid and registered or certified with return receipt requested or by delivering the same in person to such party. Notice deposited in the mail in the manner hereinabove described shall be effective only if and when
received by the parties to be notified. For purposes of Notice, the addresses of the parties shall, until changed as hereinafter provided, be as follows: 
 i. If to Purchaser: 
 Telzuit Medical Technologies, Inc. 
 Attn: Warren Stowell 
 5422 Carrier Drive, Suite
306, 
 Orlando, Florida 32819 
 or at such other addresses as the Purchaser may have advised the Sellers in writing; and 
  

 16 

 ii. If to Sellers: 

	 	

 Todd LaVelle 
 Mike Evertsen 
 2197 Canton Road, Suite 107 
 Marietta, Georgia 30066 
 or at such other address as the Sellers may
have advised the Purchaser in writing. 
 e. Headings. Headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement. 
 f. Counterpart Execution. This
Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute but one and the same instrument. 
 g. Parties in Interest. All the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be
enforceable by the Purchaser and the Sellers, their heirs, executors, administrators, successors and assigns. 
 h.
Integrated Agreement. This Agreement constitutes the entire agreement between the parties hereto, and there are no agreements, understandings, restrictions, warranties or representations between the parties other than those set forth herein
or herein provided for. 
 i. Choice of Law. It is the intention of the parties that the laws of the State of Florida
should govern the validity of this Agreement, the construction of its terms and the interpretation of the rights and duties of the parties. Venue for any legal action which may be brought thereunder shall be deemed to lie in Orange County, Florida.

 j. Attorney Fees. In the event of a default or dispute in any of the provisions hereunder which are required to be
resolved through arbitration or litigation, the prevailing party with respect to each such issue, in addition to all other remedies, shall be entitled to reasonable attorney fees, expenses and costs incurred in forcing said Agreement. 
 k. Entire Agreement. The foregoing constitutes the entire agreement and understanding of the parties on the subject hereof and
supersedes all prior agreements and understandings relating to the subject matter hereof. 
  

 17 

 IN WITNESS WHEREOF, the parties have executed this Agreement the day and year first above written.

  

									
		 	Witnesses:	 		 	Purchaser:
				
		 	  
	 		 	Telzuit Medical Technologies, Inc.
					
		 	  
	 		 	By:	 	  

					
		 		 		 	Name:	 	  

					
		 		 		 	Its:	 	  

					
		 		 		 	Sellers:	 	
				
		 	  
	 		 	  

		 		 		 	Todd LaVelle
					
		 	  
	 		 		 	
		 	  
  
	 		 	  

		 		 		 	Mike Evertsen
		 	  
	 		 		 	

  

 18Form of Consultation Agreement

 Exhibit 10.2 
 THIS DOCUMENT AND EXHIBIT “A” AND EXHIBIT “B” ATTACHED HERETO CONSTITUTE PART OF A PROSPECTUS COVERING SECURITIES THAT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 
 CONSULTATION AGREEMENT 
 WHEREAS, Telzuit Medical Technologies, Inc., a Florida corporation (the “Company”) and Todd LaVelle (“LaVelle”) and Mike Evertsen (“Evertsen”) have executed and entered
into that certain Agreement for Purchase and Sale of Shares dated July __, 2006 (the “Purchase Agreement”); and 
 WHEREAS, LaVelle and Evertsen, who are officers and were active in the business of both Atlantic Ultrasound, Inc. (“Atlantic”) and Cedars Diagnostic, Inc. (“Cedars”) prior to the
Closing Date of the Purchase Agreement, have agreed to serve as consultants to the Company for a period of three (3) months after Closing; and 
 NOW, THEREFORE, for and in consideration of the mutual covenants contained herein, LaVelle, Evertsen and the Company hereby agree as follows: 
 1. CONSULTATION: For and during the period commencing on the Closing Date of the Purchase Agreement, to wit: August 1, 2006, and ending three (3) consecutive calendar months thereafter, to wit:
October 31, 2006, LaVelle and Evertsen agree to consult with and provide consultation and advice to the Company, its agents, officers and/or employees during such customary business hours as may be requested from time to time by the Company.
The services to be rendered by LaVelle and Evertsen shall consist of business advice concerning opinions desired by the Company on matters in connection with the operation of the businesses of Atlantic and/or Cedars, relationships with suppliers,
insurance providers and governmental agencies, and relationships with customers of Atlantic and Cedars. LaVelle and Evertsen shall have the sole discretion as to the form, manner and place in which said advice shall be given, and shall at no time be
under any obligation whatsoever to render a written opinion or report in connection with any advice they may give to the Company concerning any matters of Atlantic and/or Cedars with regard to their businesses. LaVelle and Evertsen, when reasonably
requested by the Company, shall devote only such time as LaVelle and Evertsen may deem reasonable and necessary to the matters of the Company. The consultation and advice to be provided shall not in any manner be deemed to create any form of
partnership, joint venture or business association between LaVelle, Evertsen and the Company and LaVelle and Evertsen shall be and are hereby relieved and released from any liability arising in any form from the consultation and advice provided to
the Company. 
 2. CONSIDERATION: As consideration for their agreement to provide consultation and advice to the Company, the
Company shall issue in the aggregate, 277,000 shares of its common stock (the “Shares”) registered pursuant to the Company’s S-8 Registration Statement, 193,900 Shares in the name of Todd LaVelle and 83,100 Shares in the name
of Mike Evertsen; and (b) pay to LaVelle and Evertsen a lump sum payment of $12,000 payable $8,400 to LaVelle and $3,600 to Evertsen. 

 3. REPRESENTATIONS AND WARRANTIES: In connection with the issuance of the Shares, LaVelle
and Evertsen hereby represent and warrant to and agree with the Company as follows: 
 (a) One or more of the descriptions set forth below is
applicable to LaVelle and Evertsen (such applicable item(s) being marked “X” below by Subscriber) and accurately reflect(s) LaVelle’s and Evertsen’s current financial situation (please mark as many as are applicable):

  

					
	1.	  	LaVelle is a natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of the
purchase of the Shares exceeds $1,000,000.	  	 
			
	2.	  	LaVelle is a natural person whose income for each of 2004 and 2005 has exceeded $200,000, and there is a reasonable expectation that LaVelle’s income for 2006 will also be in excess of
$200,000. Such income is solely that of LaVelle and excludes the income of LaVelle’s spouse.	  	
			
	3.	  	LaVelle is a natural person whose income, together with that of his/her spouse, for each of 2004 and 2005 has exceeded $300,000, and there is a reasonable expectation that LaVelle’s income
(combined with spouse’s) for 2006 will also be in excess of $300,000.	  	

  

					
	1.	  	Evertsen is a natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of the
purchase of the Shares exceeds $1,000,000.	  	 
			
	2.	  	Evertsen is a natural person whose income for each of 2004 and 2005 has exceeded $200,000, and there is a reasonable expectation that Evertsen’s income for 2006 will also be in excess of
$200,000. Such income is solely that of Evertsen and excludes the income of Evertsen’s spouse.	  	
			
	3.	  	Evertsen is a natural person whose income, together with that of his/her spouse, for each of 2004 and 2005 has exceeded $300,000, and there is a reasonable expectation that Evertsen’s
income (combined with spouse’s) for 2006 will also be in excess of $300,000.	  	

 (b) LaVelle and Evertsen acting alone, or LaVelle and Evertsen with the assistance of the
investment advisor described below, have the requisite knowledge, experience and sophistication in financial and business matters to enable LaVelle and Evertsen and their advisor, if any, to evaluate the merits, risks and other factors bearing on a
decision to invest in the Company and so as to qualify as a “sophisticated investor” as established under relevant statutory, regulatory and judicial authority promulgated or created with regard to the Securities Act of 1933 (the
“Securities Act”). 

 (c) LaVelle and Evertsen and their investment advisor, if any, have had an opportunity to meet with
representatives of the Company and to ask questions and receive answers to their satisfaction regarding the proposed business of the Company and its financial condition in order to assist them in evaluating the merits and risks of purchasing the
Shares. All material documents and information pertaining to the Company and the investment therein that have been requested have been made available to LaVelle and Evertsen. 
 (d) At no time was LaVelle or Evertsen presented with or solicited by any advertisement, article, notice or other communication published in any
newspaper, magazine or similar medium or broadcast over radio or television or by any other form of general solicitation or general advertising. 
 5. INDEPENDENT CONTRACTOR STATUS. LaVelle and Evertsen shall provide the consulting services to the Company as independent contractors and, as such, you shall be free to exercise your own discretion and judgment in the
performance of such consulting services and with respect to the time, place, method, and manner of performance. Nothing contained in this Agreement or in the performance of any consulting services shall be construed as creating the relationship of
employer and employee between the Company and you. You understand that you will not be entitled to participate in any of the Company’s employee benefit plans or otherwise receive any insurance or other employee benefits provided to employees of
the Company. 
 6. WITHHOLDING TAX. The Company shall not withhold federal, state or local taxes with respect to the
compensation payable to you under this Agreement, and you shall bear sole responsibility for the payment of all taxes due in connection with such compensation. 
 7. ENTIRE AGREEMENT. This Agreement contains the entire agreement of the parties. There are no representations or warranties other than as contained herein. No waiver or modification hereof shall be
valid unless executed in writing with the same formalities as this Agreement. Waiver of the breach of any term or condition of this Agreement shall not be deemed a waiver of any other or subsequent breach, whether of like or of a different nature.

 8. FLORIDA LAW and VENUE. This Agreement shall be construed according to the laws of the State of Florida (exclusive of the
conflicts of law provisions thereof) and shall be binding upon the parties hereto, their successors and assigns. Venue for any legal action which may be brought hereunder shall be deemed to lie in Orange County, Florida. 
 9. ATTORNEYS’ FEES and COSTS: In the event of any litigation arising under this agreement, the prevailing party shall be entitled to
an award of attorneys’ fees and court costs, at trial and on any appeals. 
 10. TELZUIT MEDICAL TECHNOLOGIES EQUITY COMPENSATION
PLAN 
 (a) The Telzuit Medical Technologies Equity Compensation Plan (the “Plan”)The Plan, a copy of which
is attached hereto as Exhibit “A,” and the Company’s latest annual report, a copy of which is attached hereto as Exhibit “B,” are hereby incorporated by reference herein and made a part hereof for all purposes. This document
and the exhibits attached hereto constitute part of a prospectus covering securities that have been registered under the Securities Act of 1933, as amended. 

 (b) The Shares are not being issued pursuant to any provision of the Employee Retirement
Income Security Act of 1974 (“ERISA”). The Recipient may obtain additional information about the Plan by written request directed to the Company as provided in Section 7 below. The Shares will be an original issuance by the Company.

 (c) All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities and Exchange Act
of 1934 and that certain Form S-8 registration statement filed on or about September 1, 2005, as amended, are hereby incorporated by reference herein and made a part hereof for all purposes. 
 (d) The Company shall furnish to Recipient, upon oral or written request and without charge, a copy of the Plan and any document
incorporated herein by reference pursuant to Section 7 below within fifteen (15) days of receipt of such request. 
 (e) The Recipient acknowledges that he or she is aware of the historical trading volume of the shares of the Company on the OTCBB and as such, recognizes that the Shares received as compensation for services rendered hereunder may not be
able to be liquidated in a timely manner or at all. 

 IN WITNESS WHEREOF, we have hereunto set our hands and seals this
             day of July, 2006. 
  

							
	 WITNESSES
	 		 		 	
			
	  
	 		 	  
  

	  
	 		 		 	Todd LaVelle
			
	  
	 		 	  

		 		 		 	Mike Evertsen
	  
  
	 		 		 	
			
	  
	 		 	Telzuit Medical Technologies, Inc.
				
	  
	 		 	By:	 	  

				
		 		 	Name:	 	  

				
		 		 	Its:	 	  

 EXHIBIT A 
 Telzuit Medical Technologies Equity Compensation Plan 
 The document ATTACHED constitutes part of a prospectus
covering securities that have been registered under the Securities Act of 1933. 

 EXHIBIT B 
 Telzuit Medical Technologies, Inc.’s 
 Annual Report on Form 10K or 10KSB 
 The document ATTACHED constitutes part of a prospectus covering securities that have been registered under the Securities Act of 1933.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00107-of-00352.parquet"}]]